MedTrace Logo

Egyptian Hypertrophic Cardiomyopathy Program

NCT05884892 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-06-01

No results posted yet for this study

Summary

Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.

Conditions

Sponsors & Collaborators

  • Magdi Yacoub Heart Foundation

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05884892 on ClinicalTrials.gov